Institute for Clinical and Economic Review Cancels Public Meeting for Non-Alcoholic Steatohepatitis Assessment
July 02, 2020
July 02, 2020
BOSTON, Massachusetts, July 2 -- The Institute for Clinical and Economic Review issued the following announcement:
The Institute for Clinical and Economic Review (ICER) announced that it will not hold the August 2020 Midwest CEPAC public meeting to discuss the comparative clinical effectiveness and value assessment of obeticholic acid for the treatment of non-alcoholic steatohepatitis (NASH).
This decision is the result of the Food and Drug Administration recently issu . . .
The Institute for Clinical and Economic Review (ICER) announced that it will not hold the August 2020 Midwest CEPAC public meeting to discuss the comparative clinical effectiveness and value assessment of obeticholic acid for the treatment of non-alcoholic steatohepatitis (NASH).
This decision is the result of the Food and Drug Administration recently issu . . .